Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Neuroscience Letters|June 18, 2010
Nitric oxide is involved in the regulation of marble-burying behaviorMaarja Krass, Kertu Rünkorg, Gregers Wegener, et al.Neuroscience Letters|August 19, 2006
Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient miceKertu Rünkorg, Siim Värv, Toshimitsu Matsui, et al.Journal of Virology|May 7, 2002
Induction of the bovine papillomavirus origin "onion skin"-type DNA replication at high E1 protein concentrations in vivoAndres Männik, Kertu Rünkorg, Nele Jaanson, et al.International Immunopharmacology|February 19, 2013
Dual effect of nickel on L-arginine/nitric oxide system in RAW 264.7 macrophagesAnnika Volke, Kertu Rünkorg, Gregers Wegener, et al.European Journal of Pharmacology|August 5, 2020
Tolerance develops toward GLP-1 receptor agonists' glucose-lowering effect in miceTuuli Sedman, Maarja Krass, Kertu Rünkorg, et al.Behavioural Brain Research|September 20, 2011
Rimonabant attenuates amphetamine sensitisation in a CCK2 receptor-dependent mannerKertu Rünkorg, Laura Orav, Sulev Kõks, et al.Journal of Diabetes Research|April 13, 2016
Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1Tuuli Sedman, Kertu Rünkorg, Maarja Krass, et al.BMC Endocrine Disorders|October 19, 2022
Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugsVallo Volke, Urmeli Katus, Annika Johannson, et al.Acta Neuropsychiatrica|December 4, 2014
GLP-1 receptor agonists have a sustained stimulatory effect on corticosterone release after chronic treatmentMaarja Krass, Annika Volke, Kertu Rünkorg, et al.Psychopharmacology|January 25, 2003
Altered pain sensitivity and morphine-induced anti-nociception in mice lacking CCK2 receptorsAlar Veraksits, Kertu Rünkorg, Kaido Kurrikoff, et al.Pageof 2